Literature DB >> 7086702

Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide.

Y Nivoche, A Contrepois, A C Cremieux, C Carbon.   

Abstract

The pharmacokinetics, renal excretion, protein binding and extravascular diffusion of vancomycin in rabbits were studied. The effects of furosemide on these different parameters also were investigated. We observed a T 1/2 of 55 min and protein binding of 65% as determined in vitro by equilibrium dialysis. Vancomycin appeared to be secreted by renal tubules (fractional excretion: 177 +/- 44%). In vitro, furosemide (5 micrograms/ml) slightly decreased the vancomycin protein binding (from 65 to 57%). Furosemide significantly increased the renal excretion of vancomycin, through a tubular process without any effect on the filtered load. Vancomycin appeared slowly and at low concentrations in the extravascular fluid. The extravascular concentrations were higher when the antibiotic was administered by a 6-hr continuous infusion than when given by a 20-min infusion of the same dose. Our results suggested that the in vivo antibacterial effect to vancomycin could be enhanced by prolonged infusion. Also, it was demonstrated that furosemide has only a small effect on the kinetics of vancomycin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086702

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Determination of vancomycin in human serum by high-pressure liquid chromatography.

Authors:  F Jehl; C Gallion; R C Thierry; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

2.  Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.

Authors:  M Lafaurie; B Perichon; A Lefort; C Carbon; P Courvalin; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

3.  Vancomycin pharmacokinetics in burn patients and intravenous drug abusers.

Authors:  M J Rybak; L M Albrecht; J R Berman; L H Warbasse; C K Svensson
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Vancomycin pharmacokinetics in patients with various degrees of renal function.

Authors:  K A Rodvold; R A Blum; J H Fischer; H Z Zokufa; J C Rotschafer; K B Crossley; L J Riff
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

5.  Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits.

Authors:  C Carbon; F Dromer; N Brion; A C Cremieux; A Contrepois
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

6.  Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.

Authors:  B Fantin; R Leclercq; M Arthur; J Duval; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 7.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

8.  Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients.

Authors:  Dae Il Kim; Mi Sun Im; Jin Hyoung Choi; Jina Lee; Eun Hwa Choi; Hoan Jong Lee
Journal:  Korean J Pediatr       Date:  2010-12-31

9.  Does "Birth" as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias.

Authors:  Farzaneh Salem; Trevor N Johnson; Arran B J Hodgkinson; Kayode Ogungbenro; Amin Rostami-Hodjegan
Journal:  J Clin Pharmacol       Date:  2020-09-03       Impact factor: 3.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.